PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryApr 28, 2011	Integra LifeSciences Reports First Quarter 2011 Financial Results Revenues for the First Quarter Increased to $181 Million	View HTML Integra LifeSciences Reports First Quarter 2011 Financial Results 53.2 KB
Toggle SummaryApr 18, 2011	Integra LifeSciences CFO Jack Henneman Selected as a 2011 SmartCXO Winner by Philadelphia SmartCEO Magazine PLAINSBORO, N.J., April 18, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corp (Nasdaq:IART) today announced that John B. Henneman, III, Integra's Executive Vice President, Finance and Administration, and Chief Financial Officer, has been selected as one of ten winners in the Chief	View HTML Integra LifeSciences CFO Jack Henneman Selected as a 2011 SmartCXO Winner by Philadelphia SmartCEO Magazine 11.2 KB
Toggle SummaryApr 14, 2011	Integra LifeSciences Announces Instrument Repair Partnership With InstruMedics PLAINSBORO, N.J., April 14, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corp (Nasdaq:IART) today announced a partnership with InstruMedics LLC., a national provider of service and repair for surgical instruments and equipment. The relationship will allow Integra's Surgical Instrument	View HTML Integra LifeSciences Announces Instrument Repair Partnership With InstruMedics 12.6 KB
Toggle SummaryApr 12, 2011	Integra LifeSciences Announces FDA Clearance for New Indication for Accell Evo3(R) Demineralized Bone Matrix PLAINSBORO, N.J., April 12, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market Accell Evo3 ® Demineralized Bone Matrix as a bone void filler	View HTML Integra LifeSciences Announces FDA Clearance for New Indication for Accell Evo3(R) Demineralized Bone Matrix 10.8 KB
Toggle SummaryApr 11, 2011	Integra LifeSciences Receives FDA Approvals for Three Spinal Fixation Devices PLAINSBORO, N.J., April 11, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received 510k clearance from the United States Food and Drug Administration (FDA) for three new spinal intervertebral body fusion devices (IBD), continuing to	View HTML Integra LifeSciences Receives FDA Approvals for Three Spinal Fixation Devices 10.5 KB
Toggle SummaryApr 8, 2011	Integra LifeSciences Opens New Facility in Medina, Ohio PLAINSBORO, N.J., April 8, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has opened a new facility in Medina, Ohio, to house its growing spinal implant business. The facility is equipped with the latest video and communication technology,	View HTML Integra LifeSciences Opens New Facility in Medina, Ohio 11 KB
Toggle SummaryApr 5, 2011	Integra LifeSciences to Host Its First Quarter 2011 Earnings Results Conference Call on April 28, 2011 PLAINSBORO, N.J., April 5, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its first quarter 2011 financial results on Thursday, April 28, 2011. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.	View HTML Integra LifeSciences to Host Its First Quarter 2011 Earnings Results Conference Call on April 28, 2011 9.3 KB
Toggle SummaryApr 4, 2011	Integra LifeSciences Announces Three-Year Contract With Novation to Provide Jarit(R) Sterilization Containers PLAINSBORO, N.J., April 4, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has signed a three-year contract with Novation, the leading healthcare supply contracting company, to provide Jarit® sterilization containers to the members of VHA	View HTML Integra LifeSciences Announces Three-Year Contract With Novation to Provide Jarit(R) Sterilization Containers 10.2 KB
Toggle SummaryMar 9, 2011	Integra LifeSciences Features the Integra(TM) Endoscopic Gastroc Release System (EGR) Product Line at the Annual ACFAS Meeting PLAINSBORO, N.J., March 9, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is featuring the Integra(TM) Endoscopic Gastroc Release System (EGR) product line at the Annual Meeting of the American College of Foot and Ankle Surgeons (ACFAS) on	View HTML Integra LifeSciences Features the Integra(TM) Endoscopic Gastroc Release System (EGR) Product Line at the Annual ACFAS Meeting 11.4 KB
Toggle SummaryFeb 24, 2011	Integra LifeSciences to Present at the Following Four Conferences in March: Citi Global Healthcare Conference RBC Capital Markets' Healthcare Conference Raymond James' Institutional Investors Conference Barclays Capital Global Healthcare Conference PLAINSBORO, N.J., Feb. 24, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today	View HTML Integra LifeSciences to Present at the Following Four Conferences in March: 12 KB